ScreenerHero

ERF Eurofins Scientific SE

EPA · FR · Healthcare · Diagnostics & Research · eurofins.com
75.54EUR+0.91%Mkt Cap: 14.05B $P/E: 26.23

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and huma…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2
GRAL
GRAIL, Inc.
$6.88BUSD

Key Statistics

Company
Market Cap14.05B USD
Enterprise Value18.35B USD
Revenue (TTM)8.03B USD
Gross Profit5.40B USD
Net Income (TTM)516.09M USD
Revenue/Share41.84 EUR
Last Price75.54 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees65.0K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)26.23
P/E (Forward)16.12
PEG0.94
EV/EBITDA10.98
EV/Revenue2.29
P/S1.73
P/B3.59
EPS (TTM)2.88
EPS (Forward)4.64
52W Range
54.8685% of range79.22
52W High79.22 EUR
52W Low54.86 EUR
Profitability
Gross Margin68.12%
Oper. Margin16.17%
EBITDA Margin20.81%
Profit Margin6.51%
ROE10.45%
ROA4.32%
Growth
Revenue Growth2.50%
Earnings Growth28.40%
Cash Flow & Leverage
Operating CF1.52B USD
CapEx (TTM)907.39M USD
FCF Margin4.60%
FCF Yield2.63%
Net Debt4.19B USD
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity0.98
Current Ratio1.13
Quick Ratio0.87
Book Value/Sh20.85 EUR
Cash/Share3.56 EUR
Dividends
Fwd Div Rate0.72 EUR
Trail. Div Rate0.72 EUR
Div. Yield0.96%
5Y Avg Yield1.11%
Payout Ratio25.00%
Ex-Div DateApr 28, 2026
Pay Date—
Splits
Last Split10:1
Split DateNov 19, 2020
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)72.01 EUR
Upside (mean)-4.7%
Target Range58.00 EUR – 86.00 EUR
58.00-4.7% to mean86.00
# Analysts14
Ownership
Shares Out.171.11M
Float110.07M
Insiders36.50%
Institutions34.25%
Technical
SMA 5072.36 (+4.4%)
SMA 20067.13 (+12.5%)
Beta0.85
S&P 52W Chg14.58%
Avg Vol (30d)359.90K
Avg Vol (10d)348.95K
Technical Indicators
RSI (14)53.6
MACD0.9943
MACD Signal1.3171
MACD Hist.-0.3228
BB Upper80.40 EUR
BB Middle75.03 EUR
BB Lower69.65 EUR
BB Width14.33%
ATR (14)1.935 EUR
Vol Ratio (20d)1.03x